FDA Inspection 1173573 — Cecil M. Farrington, MD
The FDA completed an inspection of Cecil M. Farrington, MD on Jun 9, 2022 in Salisbury, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Salisbury, NC (United States)
Additional Details
Clinical Investigator (CI)